TSXV - Delayed Quote CAD

Medicure Inc. (MPH.V)

1.0600

+0.1200

+(12.77%)

At close: May 27 at 11:29:44 AM EDT

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results

WINNIPEG, MB / ACCESS Newswire / May 21, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC Pink:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire 6 days ago

MCUJF
Medicure Full Year 2024 Earnings: CA$0.10 loss per share (vs CA$0.088 loss in FY 2023)

Medicure ( CVE:MPH ) Full Year 2024 Results Key Financial Results Revenue: CA$21.9m (up 1.0% from FY 2023). Net loss...

Simply Wall St. 30 days ago

MCUJF
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024

WINNIPEG, MB / ACCESS Newswire / April 25, 2025 / Medicure Inc. (" Medicure " or the " Company ") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire last month

MCUJF
Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024

WINNIPEG, MB / ACCESS Newswire / April 22, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire last month

MCUJF
Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy

WINNIPEG, MB / ACCESS Newswire / April 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire last month

MCUJF
Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

WINNIPEG, MB / ACCESS Newswire / March 11, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire 2 months ago

MCUJF
Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

WINNIPEG, MB / ACCESS Newswire / February 18, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire 3 months ago

MCUJF
Medicure Reports Financial Results For Quarter Ended September 30, 2024

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported ...

ACCESS Newswire 5 months ago

MCUJF
Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present the ...

ACCESS Newswire 6 months ago

MCUJF
Medicure Announces Positive Settlement of Product Development and Supply Contracts

WINNIPEG, MB / ACCESSWIRE / October 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire 6 months ago

MCUJF
Medicure Second Quarter 2024 Earnings: CA$0.12 loss per share (vs CA$0.024 profit in 2Q 2023)

Medicure ( CVE:MPH ) Second Quarter 2024 Results Key Financial Results Revenue: CA$5.17m (down 14% from 2Q 2023). Net...

Simply Wall St. 9 months ago

MCUJF
Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property

WINNIPEG, MB / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire 9 months ago

MCUJF
Medicure Reports Financial Results for Quarter Ended June 30, 2024

WINNIPEG, ON / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire 9 months ago

MCUJF
Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property

WINNIPEG, MB / ACCESSWIRE / June 24, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers ...

ACCESS Newswire 10 months ago

MCUJF
Medicure Reports First Quarter 2024 Earnings

Medicure ( CVE:MPH ) First Quarter 2024 Results Key Financial Results Revenue: CA$5.69m (up 1.2% from 1Q 2023). Net...

Simply Wall St. 11 months ago

MCUJF
Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results

WINNIPEG, MB / ACCESSWIRE / May 28, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in ...

ACCESS Newswire 11 months ago

MCUJF

Performance Overview

Return	MPH.V	S&P/TSX Composite index (^GSPTSE)
YTD	+20.45%	+6.70%
1-Year	-2.75%	+17.41%
3-Year	-11.67%	+26.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Medicure Inc. (MPH.V)

Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results

Medicure Full Year 2024 Earnings: CA$0.10 loss per share (vs CA$0.088 loss in FY 2023)

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024

Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024

Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy

Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy

Medicure Reports Financial Results For Quarter Ended September 30, 2024

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

Medicure Announces Positive Settlement of Product Development and Supply Contracts

Medicure Second Quarter 2024 Earnings: CA$0.12 loss per share (vs CA$0.024 profit in 2Q 2023)

Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property

Medicure Reports Financial Results for Quarter Ended June 30, 2024

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property

Medicure Reports First Quarter 2024 Earnings

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results

Performance Overview